1. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FGR, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RAG, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME (2017) AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary—a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 135:e686–e725
2. Norgren L, Hiatt WR, Dormandy JA et al (2007) TASC II working group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45(Suppl):S1–S68
3. Cooke JP, Losordo DW (2015) Modulating the vascular response to limb ischemia: angiogenic and cell therapies. Circ Res 116:1561–1578
4. Madeddu P, Emanueli C, Spillmann F, Meloni M, Bouby N, Richer C, Alhenc-Gelas F, van Weel V, Eefting D, Quax PHA, Hu Y, Xu Q, Hemdahl AL, van Golde J, Huijberts M, de Lussanet Q, Boudier HS, Couffinhal T, Duplaa C, Chimenti S, Staszewsky L, Latini R, Baumans V, Levy BI (2006) Murine models of myocardial and limb ischemia: diagnostic end-points and relevance to clinical problems. Vasc Pharmacol 45:281–301
5. Huveneers S, Truong H, Danen HJ (2007) Integrins: signaling, disease, and therapy. Int J Radiat Biol 83:743–751